macrophages to pathogens 14 , which demonstrates that tissue conditioning regulates inflammatory responses triggered by the recognition of danger signals by macrophages. Among metabolic stimuli and nutrients, heme released after erythrocyte disposal triggers the formation of specialized red-pulp macrophages via induction of the transcription factor Spi-C 15 , while retinoic acid promotes the generation of peritoneal macrophages via induction of the transcription factor GATA-6, and fatty acids contribute to the activation of macrophages in obesity and thus subvert their conditioning by IL-4 produced locally [16] [17] [18] . Other examples of the effect of metabolites are lactate generated by aerobic glycolysis in tumors, which induces macrophage expression of genes encoding products critical for tumor growth 19 , and by succinate produced after the activation of macrophages by LPS, which stabilizes the transcription factor HIF-1α ('hypoxia-inducible factor 1α') and thus enhances IL-1β production 20 . Apoptotic bodies generated during development and tissue remodeling are recognized by receptors expressed by macrophages recruited in response to 'eat-me' signals and, as discussed above, have a different potential for activating macrophages depending on their pre-existing state 11, 21 . Finally, mechanical stimuli affect macrophage function, with elongation stress promoting an antiinflammatory M2 macrophage-like gene-expression program 22 .
Relaying signals by stimulus-regulated transcription factors Specific coupling of individual signals to distinct transcriptional outputs is enabled by two groups of mechanisms: first, the selective activation of a limited number of signaling pathways and transcription factors by each receptor; and second, the pre-existing repertoire of accessible genomic regulatory sequences available, on which transcription factors can land and regulate gene expression. Three broad groups of receptors particularly relevant for the activation and priming of macrophages can be identified on the basis of their coupling to pathways and transcription factors ( Fig. 2) : receptors coupled to the NF-κB and AP-1 families of transcription factors, which control a large number of genes encoding products that promote inflammation; receptors coupled to the STAT family of transcription factors; and nuclear receptors.
Receptors that activate NF-κB (via the IKKB kinase complex) 23 and AP-1 (via Jun kinases) 24 include all TLRs, members of the tumornecrosis factor (TNF) receptor superfamily (TNFRSF) such as TNF receptors I (TNFRSF1A) and II (TNFRSF1B) and CD40, as well as the type I IL-1 receptor (IL-1R1 (CD121a)). These receptors act through distinct signal transducers and adapters, which contributes to an explanation of the quantitative and kinetic differences in the activation of NF-κB and AP-1. More notably, they can be subdivided on the basis of their ability (TLR3, TLR4, RIG-I and cGAS) or inability (TNFRs and IL-1R) to trigger the phosphorylation, dimerization and nuclear entry of the transcription factor IRF3, which controls activation of the gene encoding IFN-β and the ensuing interferondependent anti-microbial response 25 .
STAT-coupled receptors 26 include the IFN-γ receptor IFNGR, which activates mainly STAT1 homodimers; the IFN-α and IFN-β (collectively called 'IFN-α/β' here) receptor IFNAR1, which activates STAT1-STAT2-IRF9 trimers with a distinct DNA-binding specificity 27 ; and the IL-4 receptor, which is coupled to STAT6 homodimers. The sets of genes activated by these receptor-transcription factor pairs reflect the distinct biological functions of the activating cytokines. While IFN-γ and IFN-α/β activate mainly genes encoding products involved in the containment of intracellular pathogens, IL-4 triggers an alternative activation program relevant to immunity to helminths, allergic reactions and metabolic homeostasis.
In addition to being influenced by signals that result from the activation of cell-surface receptors, macrophage phenotypes are influenced by intra-or extracellular signals that regulate members of the nuclear receptor superfamily. Several members of this family, including the glucocorticoid receptor, PPARγ and liver X receptors, counter-regulate the transcriptional activities of NF-κB and other pro-inflammatory transcription factors through direct and indirect mechanisms [28] [29] [30] [31] . Studies have further indicated important roles for nuclear receptors in specifying tissue-specific programs of macrophage gene expression. Local production of retinoic acid has been shown to activate retinoic acid receptors in peritoneal macrophages, which in turn induce expression of GATA-6 and other transcription factors that act together with the transcription factor PU.1 to drive a peritoneal macrophage-specific program of gene expression 16, 17, 32 . Conversely, induction of PPARγ expression by the cell-signaling molecule GM-CSF is critical for the development of alveolar macrophages and expression of genes encoding products required for their specific functions in the clearance of pulmonary surfactant 33 .
Decoding the cis-regulatory information of mammalian genomes Stimulus-regulated transcription factors (SRTFs) control gene expression by binding to the promoters and enhancers of their target genes. 35 . In contrast, the transcriptional response in macrophages is much more strongly coupled to the induction of genes encoding inflammatory mediators 36 . An important issue is understanding how specific signals direct distinct patterns of gene expression required for the specialized functions of different cell types. Signal-dependent gene expression is achieved at the level of individual genes through the actions of SRTFs on promoters and enhancers, collectively called 'cis-regulatory elements' until now (Fig. 3) . These genomic elements must be recognized and interpreted within the context of chromatin, whose fundamental subunit is the nucleosome.
Each nucleosome consists of an octamer of two copies of histones H2a, H2b, H3 and H4 encircled by approximately two turns of DNA (146 base pairs). Any given DNA fragment has a specific affinity for core histones and thus a unique ability to assemble nucleosomes 37, 38 . Affinity for histones is influenced by DNA sequence and increases with an increasing abundance of guanosine and cytosine residues 39 up to a specific point beyond which the extremely large abundance of guanosine and cytosine residues does not favor nucleosome assembly. In fact, the high concentration of guanosine and cytosine residues in CpG islands, which account for 70% of mammalian gene promoters, interferes with nucleosome assembly and thus accounts for the depletion of nucleosome at these sites [40] [41] [42] . The relevance of the association of cis-regulatory sequences with nucleosomes is indicated by the observation that transcription factor-binding sites are embedded in sequences with a high affinity for nucleosomes 43 , which suggests that transcription factors must compete with nucleosomes to gain access to regulatory DNA sequences (Fig. 3) . Figure 3 Interplay between LDTFs and SRTFs in the control of gene expression. SRTFs act at promoters (right) and enhancers (left) to direct broad or cell-restricted transcriptional responses. LDTFs (green) work together with each other and with other transcription factors to displace nucleosomes. Active promoters display high levels of H3K4me3 and are primed in many cell types by broadly expressed transcription factors. Enhancers are distinguished by high levels of H3K4me1 and are primed by LDTFs more often than promoters are. PU.1, C/EBP, AP-1 and IRF transcription factors are important macrophage lineage-determining factors that drive the selection of a large fraction of macrophage-specific enhancers. The binding of SRTFs to primed promoters and enhancers that contain their recognition motifs promotes the recruitment of co-activators that deposit H3K27ac. The binding of an SRTF to a promoter that is primed in many cell types will probably result in a broad signal-dependent response. The binding of an SRTF to a cell-specific enhancer results in a cell-restricted response or cell-specific potentiation of a broad response. GTF, general transcription factor (for example, SP-1); TSS, transcriptional start site; NFR, nucleosome-free region.
npg r e v i e w Each histone within the octamer can be altered by post-translational modifications that occur mainly at residues in their protruding amino termini, known as 'histone tails' 44 . Specific modifications are associated with different functional states. Although the precise function of different chromatin modifications is only partially understood 45 , evidence of a role for chromatin in regulating macrophage responses has been reported 46, 47 . Promoters display more trimethylation of histone H3 at Lys4 (H3K4me3) than monomethylation of H3K4 (H3K4me1) or dimethylation of H3K4 (H3K4me2), whereas enhancers exhibit high levels of H3K4me1. Acetylation of lysine residues, including histone H3 Lys9 or Lys27 (H3K27ac), and histone H4 Lys5, Lys8 or Lys12, is associated with active promoters and enhancers. Conversely, histone modifications associated with transcriptional repression include trimethylation of H3 Lys27 and H4 Lys20. Immunoprecipitation of fragmented chromatin by antibodies that recognize specific histone modifications, followed by massively parallel sequencing of the enriched DNA (ChIP-Seq), allows the derivation of genome-wide maps of these histone modifications 48 . This permits global inference of enhancers and promoters and their activity states. For example, a genomic region marked by more H3K4me1 than H3K4me3 and also marked by H3K27ac would be considered a putative active enhancer (Fig. 3) .
Through the use of ChIP-Seq to map promoters and enhancers in diverse cell types and tissues, it has been estimated that mammalian genomes contain hundreds of thousands of enhancer-like elements, which greatly exceeds the number of protein-coding genes and their promoters [49] [50] [51] . Each cell type selects from this large repertoire, on the order of 20 × 10 3 to 40 × 10 3 enhancer-like regions [49] [50] [51] -that is, regions that, given their histone-modification profile and sequence composition, are probably enhancers, although this is difficult to confirm experimentally on such a large scale. Most enhancers are active in a cell-specific manner. Because SRTFs operate at both enhancers and promoters, their actions at cell-specific enhancers are important determinants of cell-specific transcriptional responses to a given signal.
A requirement for understanding stimulus-dependent responses is thus understanding the mechanisms by which specific promoters and enhancers are selected from the genome. The cis-regulatory elements consist of combinations of binding sites for sequence-specific transcription factors clustered within a region of 150-200 nucleotides 52 . The structural organization of the nucleosome provides a physical barrier to the binding of transcription factors to the side of DNA helix facing the nucleosome. Of the hundreds of sequence-specific transcription factors expressed by a cell, only a small fraction are able to bind their recognition sequences in the context of a nucleosome 53 . Such transcription factors are often called 'pioneer factors' and largely coincide with lineage-determining transcription factors (LDTFs) (Fig. 3) -that is, transcription factors that determine cell-fate 'choices' . Since cis-regulatory sequences have a high affinity for nucleosomal histones 42, 43 and are thus partially occluded (Fig. 3) , effective binding to DNA requires the proper combination of closely spaced sequence motifs for factors with 'pioneering' activity that are expressed in that cell type. In general, promoters contain combinations of binding sites that are recognized by broadly expressed transcription factors, such as SP-1, YY-1, NFY and Gabpa 54 . Consistent with that, the H3K4me3 mark associated with promoters can be detected for one half to two thirds of all protein-encoding genes in a particular cell type. In resting macrophages, H3K4me3 marks not only the promoters of genes that are constitutively expressed but also most of the TLR4-responsive promoters before stimulation with LPS 55 . Furthermore, many of the most stimulus-responsive promoters are occupied by RNA polymerase II that has initiated the transcription of a short mRNA but is paused 30-60 nucleotides from the transcription start site 56 . In general, the presence of a large abundance of guanosine and cytosine residues or a CpG island in a promoter correlates with its constitutive association with RNA polymerase II and H3K4me3 (refs. 40,57) , which might relate both to the depletion of nucleosomes associated with these sequence features [40] [41] [42] and to the large abundance of guanosine and cytosine residues in binding sites for broadly expressed transcription factors such as SP-1 (ref. 58) . Instead, the presence at promoters of an intermediate abundance of guanosine and cytosine residues that favors nucleosome assembly imposes the requirement for chromatin-remodeling enzymes in gene activation 40, 58 . In turn, this results in a tighter regulation of gene expression and a higher dynamic range of LPS-induced expression than that of genes that contain a CpG island 58 . Moreover, changes in chromatin states at promoters underlie functional interactions between macrophageactivating stimuli. While IFN-γ is unable to activate many LPS-inducible genes, it induces histone acetylation and chromatin remodeling at their promoters and thus primes them for enhanced activation in response to LPS 59 . Overall, promoters of a large fraction of signal-responsive genes are poised for rapid responses.
The enhancers in a particular cell type show considerable enrichment for recognition motifs for pioneer factors that specify the development of that cell type, relative to the abundance of such motifs at promoters 51 (Fig. 3) . In macrophages, enhancers show considerable enrichment for motifs for the binding of PU.1, C/EBP, AP-1, IRF and RUNX transcription factors, all of which are required for the development and function of macrophages [60] [61] [62] . Furthermore, these factors reside at a large fraction of the H3K4me1-marked regions in these cells. ChIP-Seq experiments analyzing PU.1 and C/EBPα have indicated that they are present, alone or together, at nearly two thirds of the H3K4me1-marked regions 60 (this overlap is influenced by experimental and analytical issues such as the efficiency of the ChIP and the statistical thresholds used for 'calling' ChIP peaks). At enhancer-like regions occupied by both PU.1 and C/EBP or by both PU.1 and IRF8, binding is frequently mutually dependent 60, 63 . Studies using natural genetic variation as a 'mutagenesis' approach have shown that mutations in C/EBP-binding motifs abolish not only the binding of C/EBP but also that of PU.1 to nearby PU.1-recognition motifs not affected by the mutations 64 . Reciprocally, mutations in PU.1-binding motifs affect both the binding of PU.1 and the binding of C/EBP to nearby intact C/EBP-recognition motifs (Fig. 4) . Overall, while each factor is 'pioneering' , it requires collaborative interactions with the other to compete effectively with histones. Consistent with that, among the hundreds of thousands of PU.1-binding sites present in the mouse genome, which include true binding sites and random occurrences of nucleotide combinations that resemble PU.1-binding sites, those that are bound in vivo (as determined by ChIP-Seq) are located near binding sites for other lineage-determining transcription factors 42 . By extension, PU.1 and C/EBP factors are predicted to require collaborative interactions with other partners to bind to locations at which one is present without the other. Consistently, systematic analysis of motif mutations that result in altered binding of PU.1 in peritoneal macrophages and microglia has provided evidence that additional transcription factors function as collaborative partners for PU.1, including members of the AP-1, IRF, KLF and GATA families 32 . These findings suggest that PU.1, C/EBP and a handful of other macrophage lineage-determining transcription factors act together with each other and most probably with many other transcription factors to set up the macrophage-specific enhancer 'landscape' . npg r e v i e w SRTFs at pre-existing and latent enhancers An important observation that has emerged from the study of signal-dependent gene expression in macrophages is that many enhancers exist in a 'primed' (H3K4me1-positive and H3K27ac-negative) state and transition to an 'active' (H3K4me1-positive and H3K27ac-positive) state in a signal-dependent manner 61, 64, 65 . Furthermore, ChIP-Seq studies of several SRTFs, including NF-κB, STAT factors and nuclear receptors, have indicated that most signaldependent DNA-binding events occur at accessible genomic regions, many of which exhibit features of primed or active enhancers 61, [64] [65] [66] (Fig. 3) . Because these open regions of chromatin are established by macrophage LDTFs in a cell-specific manner, the patterns with which the SRTFs bind to these sites exhibit corresponding cell-specific binding patterns. The binding of factors to enhancers nearby positively regulated genes is generally associated with a gain in H3K27ac, consistent with local recruitment of histone acetyltransferases that promote the transition of primed enhancers to an active state 61, 64, 65 . These observations suggest that one mechanism by which broadly expressed SRTFs exert cell-specific functions is by being directed to pre-established enhancers associated with the appropriate set of target genes for that factor in that cell type.
While the binding of SRTFs occurs mainly at pre-existing enhancers, some stimuli promote the binding of a small percentage of such factors to closed regions of the genome and lead to the acquisition of histone modifications associated with enhancers 65, 67 . These regions, called 'latent' or 'de novo' enhancers, provide the opportunity for visualizing time-dependent intermediates in the process of enhancer selection and for determining the consequences of histone modifications following cessation of the stimulus. Binding of SRTFs to latent or de novo enhancers occurs together with and is dependent on the binding of macrophage lineage-determining factors 65, 67 , which indicates that they function as obligatory partners at these sites. However, not all SRTFs are similarly able to bind and modify regions not pre-marked by PU.1 and C/EBP. In response to LPS, AP-1 and IRF8 might have a dominant role in opening previously inaccessible genomic regions. Indeed, a large fraction of LPS-inducible IRF8-binding events occur at regions devoid of PU.1 binding 63 . Notably, many of these latent or de novo enhancers retain their histone-modification signatures following withdrawal of the initiating stimulus and are associated with a faster, stronger and more diversified response to re-stimulation than to the primary stimulation 67 . These observations suggest that the 'writing' of histone modifications provides an epigenomic memory of the prior stimulus that facilitates subsequent responses.
Intriguingly, enhancers are sites of RNA polymerase II-dependent transcription, which results in the production of capped, unstable and short enhancer RNAs (eRNAs) [68] [69] [70] [71] . Some of these eRNAs have been shown to contribute to enhancer activity 72 . Several mechanisms for this have been proposed, including contributions of eRNAs to enhancer-promoter looping 73 , recruitment of Mediator (a multi-subunit complex required for the recruitment of RNA polymerase II) 74 and displacement of NELF (a factor that negatively regulates early transcription elongation) 75 . Not all eRNAs exhibit activity, however, and the diversity of proposed mechanisms indicates that substantial additional work will be needed to determine the spectrum and general importance of eRNA-dependent mechanisms in enhancer function 76 . Enhancer transcription itself, independently of that of eRNAs, also contributes to 'writing' of the H3K4me1 and H3K4me2 enhancer signature at de novo enhancers 65 . At these locations, the binding of transcription factors is tightly coupled to histone acetylation and eRNA production and precedes the deposition of H3K4me1 and H3K4me2. Methylation of H3K4 is blocked by inhibitors of RNA polymerase II elongation and knockdown of MLL methyltransferases that control the deposition of H3K4me1 at enhancers 77, 78 . These results suggest that the 'writing' of H3K4me1 and H3K4me2 at de novo enhancers results from the recruitment of MLL proteins, possibly mediated by their binding to RNA polymerase II during elongation from enhancer transcriptional start sites.
Communication between enhancers and promoters occurs through looping, in which regions of DNA that are far apart in onedimensional space are brought into close proximity in three dimensions 79 . The definitive test of an enhancer's function is deletion of the corresponding genomic region and assessment of the consequences on gene expression. This has been performed for only a small number of putative enhancers. However, physical interactions can be evaluated in a gene-specific or genome-wide manner through chromosomeconformation-capture methods 79 . These assays indicate that the genome is organized into compartments of different scales. At the largest scale, megabase regions of active and repressed chromatin are sequestered into separate compartments. Within these compartments, the genome is subdivided into regulatory blocks or 'topologically associating domains' (TADs), with an average size of 0.8-1 megabase, that are similar across cell types. The TADs can be further subdivided into regulatory blocks of genes and their associated enhancers. Figure 4 Effect of natural genetic variation on enhancer selection and function. Two allelic forms of the genomic region are distinguished by an SNP ('T'; red font) in the recognition motif for PU.1. Genetic variant 1 preserves the PU.1-recognition motif, which enables PU.1 to bind to the DNA and act together with other LDTFs and provide access to SRTFs. Genetic variant 2 disrupts the PU.1-recognition motif, which prevents PU.1 from binding and results in corresponding loss of the binding of collaborative LDTFs and SRTFs. Because this genomic region achieves features of active enhancers only in cells that express the correct combinations of LDTFs and active SRTFs, the effects of this SNP on gene expression are specific for those cell types (for example, macrophages).
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The boundaries of TADs and the subdomains within them are frequently associated with the DNA-sequence-specific-binding protein CTCF, which is thought to have a role in constraining the regulatory activity of enhancers to their cognate genes without affecting genes in adjacent domains. These studies suggest that the organization of TADs and 'sub-TADs' determines the range over which an SRTF could operate following binding to a particular enhancer.
Enhancer landscapes in tissue-resident macrophages Nearly all studies of macrophage activation have been performed in vitro with a single stimulus or simple combinations of stimuli in controlled tissue culture environments. These powerful experimental systems will continue to elucidate the molecular mechanisms that underlie macrophage activation. For example, it has been demonstrated that it is possible to identify genes essential for the activation of TNF expression by LPS through a genome-wide CRISPR screen (a genome-editing approach based on clustered regularly interspaced short palindromic repeats and the endonuclease Cas9) of bone marrow-derived dendritic cells 80 . This screen identified many previously unrecognized regulators of TLR-dependent activation of TNF, which would indicate that there is much to learn, even for signaling pathways that have been studied intensively. Genome-wide studies have also indicated that different populations of tissue macrophages exhibit divergent patterns of gene expression that are linked to their tissue-specific homeostatic functions 81 . Furthermore, these subset-specific patterns of gene expression are determined by the local tissue environment 32, 82 . For example, the transplantation of peritoneal macrophages into the lungs results in a substantial transition of gene expression from that observed in the peritoneal cavity to a pattern more like that of alveolar macrophages 82 . The enhancer landscapes associated with different tissue-resident macrophages are also shaped by the tissue environment 32, 82 . Approximately 15-20% of the enhancers found in peritoneal macrophages are specific for that subset rather than microglia, and vice versa.
Given the in vitro observation that the binding of SRTFs occurs mainly at pre-established regulatory elements, an implication of the existence of subset-specific enhancers would be that the responses of different tissue macrophage populations to the same signal might be qualitatively and/or quantitatively different. Similar responses to the same signal would be expected for genes that exhibit the same organization of cis-regulatory elements, but genes exhibiting gain or loss of signal-dependent enhancers in one macrophage subset relative to their abundance in another subset would be expected to respond differently. Also by extension from in vitro studies that have revealed de novo enhancers, tissue-specific signals that act on SRTFs would be expected to drive gene expression through both pre-existing enhancers and the selection of new enhancers. There is emerging evidence that this is the case. For example, the gene encoding retinoic acid receptor, which is auto-regulated by retinoic acid, exhibits evidence of enhancer priming in many macrophage subsets but is particularly active in peritoneal macrophages exposed to high concentrations of endogenous retinoic acid 17, 32 . This results in peritoneal macrophagespecific expression of genes that are targets of retinoic acid receptor, which include genes encoding transcription factors such as GATA-6 that act together with PU.1 to initiate the selection of new enhancers specific to peritoneal macrophages.
The observations noted above raise the interesting question of the extent to which there is a 'core' or 'reference' macrophage epigenomethat is, a shared and subset-independent regulatory landscape-and whether it is possible to predict the responses of one macrophage subset on the basis of the responses of another. This could have practical utility, in that macrophages contribute to a broad range of diseases but are difficult to access in most tissues. An important question is whether responses of monocytes, or monocyte-derived macrophages, could be used to predict the pathological responses of macrophages in disease settings. Alternatively, knowledge of the enhancer landscapes of different macrophage subsets and the corresponding transcription factors required for their selection could be useful in 'programming' macrophages in vitro to assume more in vivo-like properties.
Regulatory variation: effect on regulation, health and disease An important outcome of genome wide association studies that have linked single-nucleotide polymorphisms (SNPs) to phenotypes of interest is that ~90% of the variants identified are in non-coding regions of the genome 83 . This would suggest an effect of such variants on the function of transcriptional regulatory elements. However, the identification of a SNP does not indicate a mechanism of action, the cell type in which it acts or the gene affected 84 . A further approach is to relate genetic variants to gene expression and thereby define expression quantitative trait loci. For example, correlation of SNPs with gene expression in monocytes and T cells of a cohort of subjects has identified hundreds of expression quantitative trait loci, a substantial fraction of which had an association restricted to either T cells or monocyte gene expression 85 . This is consistent with action of the SNP itself (or a linked variant) at a T cell-or monocyte-specific regulatory element. Interestingly, over-representation of monocyte-specific expression quantitative trait loci has been observed for variants of Alzheimer's disease and Parkinson's disease 85 , which suggests that studies of monocytes may help in predicting the functions of tissue macrophages and their effect on disease. An important future goal will be to assess the consequences of genetic variation on the selection and function of transcriptional control elements, taking advantage of the ability to measure the binding of transcription factors, the activity states of enhancers and promoters, and gene expression at genome scale. An example of this has been provided by a study of the effect of natural genetic variation on the binding and function of PPARγ, a master regulator of adipogenesis and the molecular target of antidiabetic drugs 86 . SNPs that alter the binding of PPARγ affect adipose gene expression and human metabolic disease risk. Such studies applied to macrophages are thus likely to provide insights into mechanisms that regulate gene expression and how non-coding genetic variation affects phenotypic diversity and disease.
Conclusions and future perspectives
Progress in genomics has greatly increased understanding of the transcriptional bases of macrophage responses to environmental perturbations. Current models explain how transcription factors that control macrophage development set the stage for the activity of SRTFs and how, in turn, activation changes the genomic landscape of accessible cis-regulatory elements. The same models provide an interpretative framework for the effect of genetic variability on macrophage gene-expression programs. However, most of the data converging on such models, albeit comprehensive, are correlative; systematic analysis of the role of individual cis-regulatory elements in the regulation of specific genes and in macrophage activation in response to different stimuli is the next frontier in the field.
